Logo image of IREN

IREN LTD (IREN) Stock Fundamental Analysis

NASDAQ:IREN - Nasdaq - AU0000185993 - Common Stock - Currency: USD

17.935  -0.12 (-0.64%)

Fundamental Rating

3

IREN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. IREN may be in some trouble as it scores bad on both profitability and health. IREN is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IREN had negative earnings in the past year.
In the past year IREN has reported a negative cash flow from operations.
IREN had negative earnings in each of the past 5 years.
IREN had a positive operating cash flow in 4 of the past 5 years.
IREN Yearly Net Income VS EBIT VS OCF VS FCFIREN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

IREN has a Return On Assets of -1.79%. This is comparable to the rest of the industry: IREN outperforms 59.57% of its industry peers.
IREN has a better Return On Equity (-2.50%) than 63.12% of its industry peers.
Industry RankSector Rank
ROA -1.79%
ROE -2.5%
ROIC N/A
ROA(3y)-42.61%
ROA(5y)-38.24%
ROE(3y)-51.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IREN Yearly ROA, ROE, ROICIREN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

IREN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IREN Yearly Profit, Operating, Gross MarginsIREN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

3

2. Health

2.1 Basic Checks

IREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IREN has more shares outstanding
IREN has a better debt/assets ratio than last year.
IREN Yearly Shares OutstandingIREN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
IREN Yearly Total Debt VS Total AssetsIREN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

IREN has an Altman-Z score of 3.86. This indicates that IREN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.86, IREN is in the better half of the industry, outperforming 62.77% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that IREN is not too dependend on debt financing.
IREN's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. IREN outperforms 68.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.86
ROIC/WACCN/A
WACC10.68%
IREN Yearly LT Debt VS Equity VS FCFIREN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.46 indicates that IREN may have some problems paying its short term obligations.
IREN's Current ratio of 0.46 is on the low side compared to the rest of the industry. IREN is outperformed by 91.13% of its industry peers.
A Quick Ratio of 0.46 indicates that IREN may have some problems paying its short term obligations.
With a Quick ratio value of 0.46, IREN is not doing good in the industry: 90.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
IREN Yearly Current Assets VS Current LiabilitesIREN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.75% over the past year.
IREN shows a strong growth in Revenue. In the last year, the Revenue has grown by 149.98%.
IREN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 188.02% yearly.
EPS 1Y (TTM)90.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)149.98%
Revenue growth 3Y188.02%
Revenue growth 5YN/A
Sales Q2Q%172.49%

3.2 Future

Based on estimates for the next years, IREN will show a very strong growth in Earnings Per Share. The EPS will grow by 211.02% on average per year.
IREN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 72.11% yearly.
EPS Next Y178.24%
EPS Next 2Y439.19%
EPS Next 3Y211.02%
EPS Next 5YN/A
Revenue Next Year161.77%
Revenue Next 2Y117.03%
Revenue Next 3Y72.11%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IREN Yearly Revenue VS EstimatesIREN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
IREN Yearly EPS VS EstimatesIREN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

IREN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 20.51, the valuation of IREN can be described as rather expensive.
IREN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IREN is cheaper than 76.60% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IREN to the average of the S&P500 Index (36.52), we can say IREN is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 20.51
IREN Price Earnings VS Forward Price EarningsIREN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IREN Per share dataIREN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

IREN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IREN's earnings are expected to grow with 211.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y439.19%
EPS Next 3Y211.02%

More info and screens

0

5. Dividend

5.1 Amount

IREN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IREN LTD

NASDAQ:IREN (7/18/2025, 3:25:09 PM)

17.935

-0.12 (-0.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners58.1%
Inst Owner ChangeN/A
Ins Owners4.39%
Ins Owner Change45.46%
Market Cap4.03B
Analysts83.33
Price Target20.78 (15.86%)
Short Float %15.48%
Short Ratio1.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)171.1%
Min EPS beat(2)-22.73%
Max EPS beat(2)364.93%
EPS beat(4)1
Avg EPS beat(4)-232.62%
Min EPS beat(4)-1085.5%
Max EPS beat(4)364.93%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.74%
Min Revenue beat(2)-8.9%
Max Revenue beat(2)1.42%
Revenue beat(4)1
Avg Revenue beat(4)-4.4%
Min Revenue beat(4)-8.9%
Max Revenue beat(4)1.42%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.32%
PT rev (3m)-5.89%
EPS NQ rev (1m)-2.34%
EPS NQ rev (3m)-37.14%
EPS NY rev (1m)-77.38%
EPS NY rev (3m)-91.99%
Revenue NQ rev (1m)-0.42%
Revenue NQ rev (3m)-7.38%
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-5.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.51
P/S 10.61
P/FCF N/A
P/OCF N/A
P/B 2.82
P/tB 2.82
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)0.87
Fwd EY4.88%
FCF(TTM)-2.56
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS1.69
BVpS6.35
TBVpS6.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.79%
ROE -2.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.61%
ROA(5y)-38.24%
ROE(3y)-51.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 110.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z 3.86
F-Score4
WACC10.68%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)123.51%
Cap/Sales(5y)130.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y178.24%
EPS Next 2Y439.19%
EPS Next 3Y211.02%
EPS Next 5YN/A
Revenue 1Y (TTM)149.98%
Revenue growth 3Y188.02%
Revenue growth 5YN/A
Sales Q2Q%172.49%
Revenue Next Year161.77%
Revenue Next 2Y117.03%
Revenue Next 3Y72.11%
Revenue Next 5YN/A
EBIT growth 1Y44.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5464.19%
EBIT Next 3Y384.47%
EBIT Next 5YN/A
FCF growth 1Y18.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y771.34%
OCF growth 3Y210.56%
OCF growth 5YN/A